C21 Investments Inc
C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll … Read more
Market Cap & Net Worth: C21 Investments Inc (CXXIF)
C21 Investments Inc (OTCQX:CXXIF) has a market capitalization of $16.75 Million ($16.75 Million) as of March 18, 2026. Listed on the OTCQX stock exchange, this USA-based company holds position #26834 globally and #9041 in its home market, demonstrating a -25.32% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying C21 Investments Inc's stock price $0.14 by its total outstanding shares 118040067 (118.04 Million).
C21 Investments Inc Market Cap History: 2018 to 2025
C21 Investments Inc's market capitalization history from 2018 to 2025. Data shows change from $252.45 Million to $16.75 Million (-30.24% CAGR).
C21 Investments Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how C21 Investments Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.56x
C21 Investments Inc's market cap is 0.56 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $66.65 Million | $2.59 Million | -$23.60 Million | 25.78x | N/A |
| 2020 | $166.44 Million | $37.71 Million | -$32.56 Million | 4.41x | N/A |
| 2021 | $59.26 Million | $36.13 Million | -$6.11 Million | 1.64x | N/A |
| 2022 | $23.02 Million | $32.98 Million | $10.92 Million | 0.70x | 2.11x |
| 2023 | $29.98 Million | $28.89 Million | $293.21K | 1.04x | 102.25x |
| 2024 | $27.62 Million | $28.29 Million | -$3.31 Million | 0.98x | N/A |
| 2025 | $16.75 Million | $30.12 Million | -$3.97 Million | 0.56x | N/A |
Competitor Companies of CXXIF by Market Capitalization
Companies near C21 Investments Inc in the global market cap rankings as of March 18, 2026.
Key companies related to C21 Investments Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
C21 Investments Inc Historical Marketcap From 2018 to 2025
Between 2018 and today, C21 Investments Inc's market cap moved from $252.45 Million to $ 16.75 Million, with a yearly change of -30.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $16.75 Million | -39.36% |
| 2024 | $27.62 Million | -7.87% |
| 2023 | $29.98 Million | +30.26% |
| 2022 | $23.02 Million | -61.16% |
| 2021 | $59.26 Million | -64.40% |
| 2020 | $166.44 Million | +149.73% |
| 2019 | $66.65 Million | -73.60% |
| 2018 | $252.45 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of C21 Investments Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.75 Million USD |
| MoneyControl | $16.75 Million USD |
| MarketWatch | $16.75 Million USD |
| marketcap.company | $16.75 Million USD |
| Reuters | $16.75 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.